AIM ImmunoTech Reports Positive Topline Results from Phase 2

Efficacy results offer preliminary evidence that Ampligen may reduce fatigue in subjects with Post-COVID conditions Safety results show Ampligen is generally well tolerated in the treatment of...

Related Keywords

United States , American , Chris Mcaleer , Thomask Equels , Linkedin , Exchange Commission , Company Phase , Twitter , Facebook , Immunotech Inc , Fatigue Score , Six Minute Walk Test , Executive Officer Thomas , Officer Chris Mcaleer , Private Securities Litigation Reform Act , Markets ,